Table 1.
Group | Treatment | Serum glucose (mg/dL) (Mean ± SEM)
|
||||
---|---|---|---|---|---|---|
Time after glucose administration in minutes | ||||||
0 | 30 | 60 | 90 | 120 | ||
I | Control | 67.53 ± 4.20 | 107.81 ± 4.40 | 137.12 ± 4.12 | 151.7 ± 4.26 | 115.27 ± 5.20 |
II | Standard | 61.54 ± 6.87 | 71.35 ± 6.02a | 68.12 ± 5.99a | 73.12 ± 6.30a | 64.12 ± 5.96a |
III | AGLE | 70.24 ± 4.29 | 82.12 ± 4.20a | 94.12 ± 5.60a | 97.12 ± 4.11a | 67.43 ± 5.20a |
IV | MILE | 57.34 ± 4.91 | 94.20 ± 5.25a | 110.12 ± 5.20a | 94.20 ± 5.01a | 78.6 ± 4.08a |
V | AGLE + MILE | 55.06 ± 5.67 | 90.74 ± 4.93a | 80.12 ± 5.12a | 71.13 ± 5.14a | 60.14 ± 4.02a |
Notes:
P < 0.001, when compared to control (G-I).
Abbreviations: AGLE, Asystasia gangetica leaf extract; MILE, Morus indica leaf extract.